ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 580,03
-0,69%
Dow Jones
40 827,90
1,53%
DAX
18 518,03
-0,44%
Brent Oil
83,325
-1,20%
Bitcoin
64 236,96
-0,95%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
27/07/201622h00Dow Jones NewsTeva, Allergan Get FTC Approval for Generics PurchaseNYSE:TEVATeva Pharmaceutical Industries Ltd
27/07/201620h53Edgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
27/07/201620h36Business WireTeva Receives Clearance from the U.S. Federal Trade Commission for Actavis Generics AcquisitionNYSE:TEVATeva Pharmaceutical Industries Ltd
21/07/201620h52Business WireTeva Announces Pricing of Additional CHF1.0 Billion of Senior Notes in Connection with Pending Acquisition of Actavis GenericsNYSE:TEVATeva Pharmaceutical Industries Ltd
20/07/201622h03Business WireTeva Announces Pricing of Additional €4.0 Billion of Senior Notes in Connection with Pending Acquisition of Actavis GenericsNYSE:TEVATeva Pharmaceutical Industries Ltd
19/07/201623h18Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NYSE:TEVATeva Pharmaceutical Industries Ltd
19/07/201612h05Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NYSE:TEVATeva Pharmaceutical Industries Ltd
19/07/201603h17Business WireTeva Announces Pricing of $15 Billion of Senior Notes in Connection with Pending Acquisition of Actavis GenericsNYSE:TEVATeva Pharmaceutical Industries Ltd
19/07/201600h11Dow Jones NewsTeva Sells $15 Billion of BondsNYSE:TEVATeva Pharmaceutical Industries Ltd
18/07/201623h46Dow Jones NewsADRs End Higher; ARM Holdings SoarsNYSE:TEVATeva Pharmaceutical Industries Ltd
18/07/201621h03Dow Jones NewsTeva Finalizes Bond Sale -- UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
18/07/201620h10Dow Jones NewsTeva Finalizes Bond SaleNYSE:TEVATeva Pharmaceutical Industries Ltd
14/07/201600h33Dow Jones NewsADRs End Mostly Lower; Nokia RisesNYSE:TEVATeva Pharmaceutical Industries Ltd
13/07/201616h40Edgar (US Regulatory)Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr)NYSE:TEVATeva Pharmaceutical Industries Ltd
13/07/201615h50Dow Jones NewsTeva, Allergan Tweak Acquisition AgreementNYSE:TEVATeva Pharmaceutical Industries Ltd
13/07/201615h36Dow Jones NewsU.S. Hot Stocks: Hot Stocks to WatchNYSE:TEVATeva Pharmaceutical Industries Ltd
13/07/201601h20Dow Jones NewsTeva Raises GuidanceNYSE:TEVATeva Pharmaceutical Industries Ltd
12/07/201622h01Business WireTeva to Host Conference Call and Webcast to Provide Preliminary Outlook for 2016-2019NYSE:TEVATeva Pharmaceutical Industries Ltd
05/07/201617h01Business WireTeva & the Huntington Study Group Announce Publication of Pivotal Phase III Data on Deutetrabenazine (SD-809) in Huntington D...NYSE:TEVATeva Pharmaceutical Industries Ltd
28/06/201614h00Business WireTeva Announces FDA Acceptance of New Drug Applications for Fluticasone Propionate/Salmeterol & Fluticasone Propionate RespiCl...NYSE:TEVATeva Pharmaceutical Industries Ltd
28/06/201602h13Dow Jones NewsMayne Pharma Buys US Drugs from Teva, Allergan for $652 MillionNYSE:TEVATeva Pharmaceutical Industries Ltd
27/06/201614h30Business WireTeva and Antares Pharma Announce Launch of Generic Imitrex® in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
27/06/201614h00PR Newswire (US)Analysts View on Drug Manufacturers - Other Equities - Endo Intl., Teva Pharma, Synergy Pharma, and Orexigen TherapeuticsNYSE:TEVATeva Pharmaceutical Industries Ltd
24/06/201613h11Business WireTeva Receives CHMP Positive Opinion for CINQAERO® (reslizumab)NYSE:TEVATeva Pharmaceutical Industries Ltd
23/06/201614h30Business WireTeva Settles Patent Litigation with AstraZeneca Allowing Teva to Commercialize Its Generic Version of Byetta® (Exenatide Inj...NYSE:TEVATeva Pharmaceutical Industries Ltd
21/06/201615h30Dow Jones NewsTeva and Allergan Sell Generic Drugs to Impax In Latest DivestitureNYSE:TEVATeva Pharmaceutical Industries Ltd
20/06/201614h00Business WireTeva to Present Data Highlighting SD-809 at 20th International Congress of Parkinson’s Disease and Movement DisordersNYSE:TEVATeva Pharmaceutical Industries Ltd
16/06/201617h07Dow Jones NewsTeva, Looking to Close Actavis Deal, Sells $40 Million Portfolio to SagentNYSE:TEVATeva Pharmaceutical Industries Ltd
15/06/201602h11Dow Jones NewsLilly: German Supreme Court Grants Appeal in Dispute With ActavisNYSE:TEVATeva Pharmaceutical Industries Ltd
13/06/201614h00Business WireTeva Announces Voluntary Suspension of Marketing for ZECUITY® in the U.S.NYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

NYSE
JPM
JP Morgan Chase
EU
BNP
BNP Paribas
EU
AI
Air Liquide
COIN
ETHUSD
Ethereum
EU
AF
Air FranceKLM
NYSE
DIS
Walt Disney
EU
SGO
Cie de SaintGobain
EU
MC
Lvmh Moet Hennessy Louis...
NASDAQ
GOOGL
Alphabet
EU
DG
Vinci
NYSE
NKE
Nike
NYSE
MCD
McDonalds
EU
ACA
Credit Agricole
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés